Baron, Nathalie .
HRN: 26-42-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2024
CEFUROXIME 750MG (VIAL)
12/28/2024
01/04/2025
IV
465
Q8h
Complex Febrile Seizure
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes